Atada a Tu Volcán

Atadas Inc. and Spero Health partner to increase multi-state patient retention in outpatient addiction treatment and success of medication-assisted treatment programs

Retrieved on: 
Wednesday, July 5, 2023

NASHVILLE, Tenn., July 5, 2023 /PRNewswire-PRWeb/ -- Atadas Inc., a telehealth technology company, and Spero Health, an outpatient provider specializing in addiction treatment of substance use disorders, joined forces to expand a unique patient-retention technology platform, AddMedPro, across the six states in which Spero Health operates. The technology changes the way medication-assisted treatments are personalized to meet the specific needs of patients by delivering remote, patient-centered, evidence-based feedback for increased retention, and enhanced provider-patient connections.

Key Points: 
  • Atadas and Spero Health partner to offer a unique patient-retention technology platform to treat addiction, called AddMedPro, across the six states in which Spero Health operates.
  • NASHVILLE, Tenn., July 5, 2023 /PRNewswire-PRWeb/ -- Atadas Inc., a telehealth technology company, and Spero Health, an outpatient provider specializing in addiction treatment of substance use disorders, joined forces to expand a unique patient-retention technology platform, AddMedPro, across the six states in which Spero Health operates.
  • A teammate-based approach to treatment allows patients to continue working and caring for their families as they overcome addiction.
  • CEO Steve Priest said, "Tens of thousands of patients turn to Spero Health daily as they begin their recovery journey.

Atadas Receives Patent for First-to-Market Remote Medication Monitoring Technology

Retrieved on: 
Wednesday, March 16, 2022

NASHVILLE, Tenn., March 16, 2022 /PRNewswire-PRWeb/ -- Atadas Inc., a telehealth technology company, has been awarded a U.S. patent for a remote medication monitoring (RMM) technology, referred to as PillCountPro, that transforms the way medicated assistant treatments (MAT) can be implemented.

Key Points: 
  • NASHVILLE, Tenn., March 16, 2022 /PRNewswire-PRWeb/ -- Atadas Inc., a telehealth technology company, has been awarded a U.S. patent for a remote medication monitoring (RMM) technology, referred to as PillCountPro, that transforms the way medicated assistant treatments (MAT) can be implemented.
  • "Most medication adherence solutions focus on medication reminders and refills," explains Bill Farr, co-founder and CEO, Atadas.
  • "Our technology provides an evidence-based feedback mechanism allowing medication monitoring between refills, delivering vital real-time data to the provider regarding treatment effectiveness.
  • Atadas is a telehealth company leveraging technology and software to address the challenges physicians, patients and the pharmaceutical industry face in medication management.

Atadas Inc. Offers First-of-its-Kind Software for Office-Based Opioid Treatment

Retrieved on: 
Tuesday, November 30, 2021

CLEARFIELD, Utah, Nov. 30, 2021 /PRNewswire-PRWeb/ --Atadas, a leading provider of software for medication-assisted treatment (MAT), has launched AddMedPro telehealth platform, an easy-to use, cloud-based patient management software application specifically built for Office-Based Opioid Treatment (OBOT) practices.

Key Points: 
  • CLEARFIELD, Utah, Nov. 30, 2021 /PRNewswire-PRWeb/ --Atadas, a leading provider of software for medication-assisted treatment (MAT), has launched AddMedPro telehealth platform, an easy-to use, cloud-based patient management software application specifically built for Office-Based Opioid Treatment (OBOT) practices.
  • A fully integrated and collaborative care platform, AddMedPro includes needed provisions to support an OBOT practice and enables full compliance with state and government regulations.
  • Atadas helps doctors in their treatment of patients with Opioid Use Disorder (OUD).
  • The company's systems provide Office-Based Opioid Treatment (OBOT) practices with tools to manage their practice and monitor patients more efficiently and effectively.